Quality key factors
Factor
Value
Sales Growth (5y)
29.40%
EBIT Growth (5y)
12.07%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
39.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.94
EV to EBIT
14.88
EV to EBITDA
12.62
EV to Capital Employed
2.37
EV to Sales
1.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.96%
ROE (Latest)
9.68%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
5What is working for the Company
NET SALES(HY)
At CNY 782.33 MM has Grown at 22.03%
PRE-TAX PROFIT(Q)
Highest at CNY 59.9 MM
NET PROFIT(Q)
Highest at CNY 51.04 MM
EPS(Q)
Highest at CNY 0.29
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 16.44% (YoY
Here's what is working for Shandong Boyuan Pharmaceutical & Chemical Co. Ltd.
Net Sales
At CNY 782.33 MM has Grown at 22.03%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY 59.9 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 51.04 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.29
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Here's what is not working for Shandong Boyuan Pharmaceutical & Chemical Co. Ltd.
Raw Material Cost
Grown by 16.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






